Chemotherapy and Abdominal mass

Summary:

Abdominal mass is found among people with Chemotherapy, especially for people who are female, 50-59 old.

The study analyzes which people have Abdominal mass with Chemotherapy. It is created by eHealthMe based on reports of 16 people who have Chemotherapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Chemotherapy?

Chemotherapy is found to be associated with 223 drugs and 470 conditions by eHealthMe. Check the latest studies of Chemotherapy.

What is Abdominal mass?

Abdominal mass (localized enlargement or swelling in the human abdomen) is found to be associated with 447 drugs and 1,107 conditions by eHealthMe. Check the latest studies of Abdominal mass.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

16 people who have Chemotherapy and Abdominal Mass are studied.

Would you have Abdominal mass when you have Chemotherapy?

Gender of people who have Chemotherapy and experienced Abdominal Mass *:

female: 53.33 %
male: 46.67 %

Age of people who have Chemotherapy and experienced Abdominal Mass *:

Common co-existing conditions for these people *:

Breast Cancer: 3 people, 18.75%
Oedema (fluid collection in tissue): 2 people, 12.50%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 12.50%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 12.50%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 6.25%
Immunodeficiency Disorders: 1 person, 6.25%

Common drugs taken by these people *:

Cisplatin: 4 people, 25.00%
Mitoxantrone: 3 people, 18.75%
Cytarabine: 3 people, 18.75%
Neulasta: 3 people, 18.75%
Piperacillin And Tazobactam: 2 people, 12.50%
Cyclophosphamide: 2 people, 12.50%
Imodium: 2 people, 12.50%
Zoledronic Acid: 2 people, 12.50%
Oxaliplatin: 1 person, 6.25%
Protonix: 1 person, 6.25%

Common symptoms for these people *:

Diarrhea: 6 people, 37.50%
Hypotension (abnormally low blood pressure): 6 people, 37.50%
Fever: 4 people, 25.00%
Fall: 4 people, 25.00%
Dehydration (dryness resulting from the removal of water): 3 people, 18.75%
Malignant Neoplasm Progression (cancer tumour came back): 3 people, 18.75%
Clostridial Infection (infectious conditions by clostridium bacteria): 3 people, 18.75%
Benign Colonic Neoplasm (benign (non-cancerous) tumours of the adrenal gland): 3 people, 18.75%
Hepatomegaly (abnormal enlargement of the liver): 3 people, 18.75%
Atelectasis (partial or complete collapse of the lung): 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Abdominal mass?

- Check whether Abdominal mass is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Chemotherapy (40,256 reports)
Abdominal mass (3,416 reports)

All the drugs that are associated with Abdominal mass:

Abdominal mass (447 drugs)

All the conditions that are associated with Abdominal mass:

Abdominal mass (1,107 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Abdominal mass and Chemotherapy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.